Alzheimer’s could be diagnosed with common blood test
Researchers find neuroprotective blood protein that is a biomarker for Alzheimer's disease and also correlates with IQ.
The progressive dementia of Alzheimer’s disease affects some 35 million people worldwide and is expected to affect 115 million by 2050, yet currently it is not possible to detect the disease before it has caused loss of memory and function. Even then, the tests available are invasive and/or expensive.
Read Full Article...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy